PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

butorphanol

Verify with FDA → · CMS NADAC pricing →

Brand names: Stadol

Opioid Agonist-Antagonist Rx

Butorphanol nasal spray is a strong pain medicine. It is used when other pain medicines are not strong enough or cannot be tolerated.

Drug Pricing (NADAC)

Generic Price

$12.56/unit

Generic Available

Yes (4 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

What it does

This medicine treats severe pain that requires an opioid pain reliever.

Common side effects

Sleepiness, Dizziness, Nausea

Key warnings

This medicine has serious warnings.

How It Works

Butorphanol is an opioid agonist-antagonist. It works by changing how your brain and nervous system respond to pain. It attaches to certain receptors in the brain to reduce pain signals.

How to Take It

Only a healthcare provider who knows about opioid medicines should prescribe this nasal spray. Use the lowest dose that works for the shortest time needed. For each spray, prime the pump by pressing firmly and releasing several times. If you don't use it for 48 hours, you will need to prime it again.

Pregnancy & Breastfeeding

If you need to use this medicine for a long time during pregnancy, it can cause withdrawal symptoms in your newborn. Make sure a newborn specialist is available when you deliver your baby.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time.

Storage

Store at room temperature between 68°F to 77°F and keep it in a safe place.

Side Effects (from patient reports)

Based on 245 FDA adverse event reports.

Allergic reaction to the drug
48
Drug not working
45
Missed dose
36
Feeling sick to your stomach
25
Head pain
16
Discomfort
16
Itching
16
Throwing up
15
Feeling worried or nervous
14
Difficulty breathing
14

FDA Adverse Event Report Analysis

Detailed analysis of 318 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2002–2025.

Total Reports

318

Death-Related Reports

7

Hospitalization Reports

48

Top Indication

Migraine

Gender Distribution

Female 244 (84%)
Male 48 (16%)

Age Distribution

0–17 2
18–44 42
45–64 85
65–74 19
75+ 17

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 DRUG HYPERSENSITIVITY 48
2 DRUG INEFFECTIVE 45
3 PRODUCT DOSE OMISSION ISSUE 36
4 NAUSEA 25
5 HEADACHE 16
6 PAIN 16
7 PRURITUS 16
8 VOMITING 15
9 ANXIETY 14
10 DYSPNOEA 14
11 MIGRAINE 13
12 PRODUCT QUALITY ISSUE 13
13 DIZZINESS 12
14 PRODUCT PACKAGING QUANTITY ISSUE 11
15 DEPRESSION 10

Reactions in Death Reports

CARDIAC FAILURE 2
PNEUMONIA 2
PNEUMONITIS 2
ABDOMINAL DISTENSION 1
BRAIN CONTUSION 1
BRAIN HERNIATION 1
BRAIN OEDEMA 1
BURNING SENSATION 1
CAROTID ARTERY THROMBOSIS 1
CEREBRAL HAEMORRHAGE 1

Reactions in Hospitalization Reports

DYSPNOEA 8
ANXIETY 7
PAIN 7
FATIGUE 6
HEADACHE 6
NAUSEA 6
PNEUMONIA 6
DEPRESSION 5
HYPOAESTHESIA 5
CEREBROVASCULAR ACCIDENT 4

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

This medicine has serious warnings. It can cause addiction, abuse, and misuse, which can lead to overdose and death. It can also cause life-threatening breathing problems, especially when you first start using it or after a dose increase. Accidental use, even one dose, can cause a fatal overdose, especially in children. Using this medicine with benzodiazepines or other drugs that can make you sleepy, including alcohol, can cause serious problems, including coma and death. If you use this medicine for a long time during pregnancy, it can cause withdrawal symptoms in the newborn that could be life-threatening if not treated.

Known Drug Interactions

moderate oxycodone

Intervention: Avoid concomitant use Examples: Butorphanol, nalbuphine, pentazocine, buprenorphine Muscle Relaxants Clinical Impact: Oxycodone may enhance the neuromuscular blocking action of skeletal muscle relaxants and produce an increased degree of respiratory depression.

Mechanism: These drugs both slow down your breathing and can make your muscles very weak when taken together.

What to do: You should avoid using these two medications at the same time.

Mixed Agonist/Antagonist and Partial Agonist Opioid Analgesics The concomitant use of opioids with other opioid analgesics, such as butorphanol, nalbuphine, pentazocine, may reduce the analgesic effect of PERCOCET and/or precipitate withdrawal symptoms.

Mechanism: Butorphanol can block the pain-relieving effects of oxycodone and may cause sudden withdrawal symptoms. This happens because the two drugs compete for the same spots in your body's nervous system.

What to do: Avoid using these two types of pain medications together to ensure your pain is managed and to prevent withdrawal.

Examples: butorphanol, nalbuphine, pentazocine Muscle Relaxants Clinical Impact: Buprenorphine may enhance the neuromuscular blocking action of skeletal muscle relaxants and produce an increased degree of respiratory depression.

Mechanism: These medicines can work together to slow your breathing and make your muscles very weak. This increases the risk of serious breathing problems.

What to do: Your doctor should monitor you for slow breathing and may need to adjust your treatment plan.

minor codeine

Mixed Agonist/Antagonist and Partial Agonist Opioid Analgesics The concomitant use of opioids with other opioid analgesics, such as butorphanol, nalbuphine, pentazocine, may reduce the analgesic effect of acetaminophen and codeine phosphate tablets and/or precipitate withdrawal symptoms.

Mechanism: Butorphanol can block the pain-relieving effects of codeine and may cause sudden, uncomfortable withdrawal symptoms.

What to do: Avoid using these two medicines at the same time to ensure your pain is managed safely.

Examples: Butorphanol, nalbuphine, pentazocine, buprenorphine.

Mechanism: Butorphanol can block the pain-relieving effects of fentanyl or cause sudden withdrawal symptoms because it works differently on the same brain receptors.

What to do: Avoid using these two medicines together. Your doctor may need to adjust your pain management plan.

Check all your medications →

Common Questions

Can this medicine cause addiction?
Yes, this medicine is an opioid and can be addictive, even when used as prescribed.
What should I do if I accidentally spray this in my child's face?
Accidental exposure of even one dose of this medicine, especially in children, can result in a fatal overdose. Seek emergency medical attention immediately.
Can I drink alcohol while using this medicine?
No, drinking alcohol while using this medicine can cause severe sleepiness, breathing problems, coma, and death.
How many sprays are in one bottle?
One bottle will deliver 14 to 15 doses if you don't need to re-prime the spray.
What should I do if I have trouble breathing?
Seek emergency medical attention immediately. This medicine can cause life-threatening breathing problems.
Can I drive while taking this medicine?
This medicine can cause sleepiness and dizziness. Do not drive or operate heavy machinery until you know how this medicine affects you.
What is naloxone?
Naloxone is a medicine that can reverse an opioid overdose. Talk to your doctor about whether you should have naloxone available.
What should I tell my doctor before taking this medicine?
Tell your doctor if you have any breathing problems, a history of drug abuse or addiction, or any other medical conditions.
How often can I use this nasal spray?
Use this medicine exactly as prescribed by your doctor. Do not use it more often or for longer than prescribed.
What if this medicine stops working?
Talk to your doctor if this medicine stops working. Do not increase your dose without talking to your doctor first.
What are the common side effects of butorphanol?
The most commonly reported side effects of butorphanol include Sleepiness, Dizziness, Nausea, Vomiting, Nasal congestion. Based on 245 FDA adverse event reports. Always consult your healthcare provider about potential side effects.
Does butorphanol interact with other medications?
Yes, butorphanol has 11 known drug interactions. Notable interactions include oxycodone, acetaminophen/oxycodone, buprenorphine (pain). Always inform your doctor about all medications you are taking.
What drug class is butorphanol?
butorphanol belongs to the Opioid Agonist-Antagonist drug class. It requires a prescription (Rx). This medicine treats severe pain that requires an opioid pain reliever.
Is butorphanol safe during pregnancy?
If you need to use this medicine for a long time during pregnancy, it can cause withdrawal symptoms in your newborn. Make sure a newborn specialist is available when you deliver your baby. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.

Related Medications in Opioid Agonist-Antagonist

Other drugs grouped near butorphanol — same-class peers and common alternatives.

Compare butorphanol vs abatacept side-by-side →

Medication Guides

Related Health & Safety Data

Save on butorphanol

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for butorphanol

The FDA label for butorphanol (sold under brand names such as Stadol) classifies it as a prescription-only medication in the Opioid Agonist-Antagonist class. This medicine treats severe pain that requires an opioid pain reliever. Official labeling lists 6 commonly reported side effects, including Sleepiness, Dizziness, Nausea.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 245 voluntary reports. The database also lists 11 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS shows a generic unit cost of $12.56.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: April 17, 2024

All federal data sources used on this page